China's Botox boom a boon for HK firm

Hong Kong

FRETTING about frown lines and crow's feet can start early. In China, women in their 20s and 30s are spending on therapies to smooth their wrinkles - a growing trend Union Medical Healthcare wants to meet.

Union Medical, Hong Kong's biggest provider of the wrinkle treatment Botox, raised HK$742.4 million (S$131 million) in an initial public offering earlier this month to fund acquisitions and capital expenditure that will expand its network of Dr Reborn clinics in the territory and on the mainland.